Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLI and Methotrexate for Immune Reconstitution after CD34+ Selected Transplant
NCT01027702Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2009
- Primary completion
- Nov 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocyte infusion in immunodeficiency, sponsored by Wake Forest University Health Sciences. Started Aug 2009; status: terminated.
02
Drugs
donor lymphocyte infusion
03
Conditions
immunodeficiency
Beyond the preview
Go deeper on NCT01027702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027702.